Astellas

Astellas's carbon emissions reporting for 2024 shows a total of approximately 1.38 billion kg CO2e. This figure encompasses Scope 1 emissions of approximately 52.21 million kg CO2e, Scope 2 emissions of approximately 55.62 million kg CO2e, and substantial Scope 3 emissions amounting to approximately 1.28 billion kg CO2e. The pharmaceutical manufacturer's Scope 3 emissions are largely driven by purchased goods and services, which contribute approximately 1.08 billion kg CO2e.

Looking at previous years, Astellas reported a total of approximately 1.12 billion kg CO2e in 2023, with Scope 1 at roughly 59.20 million kg CO2e, Scope 2 at approximately 63.05 million kg CO2e, and Scope 3 at approximately 1.12 billion kg CO2e. In 2022, the company's total emissions were approximately 1.01 billion kg CO2e, comprising Scope 1 at around 61.17 million kg CO2e, Scope 2 at approximately 56.47 million kg CO2e, and Scope 3 at about 893.62 million kg CO2e.

Astellas has set ambitious climate commitments, including achieving Net Zero GHG emissions by 2050. For near-term targets, the company aims to reduce absolute Scope 1 and 2 GHG emissions by 63% by fiscal year 2030, using fiscal year 2015 as the base year. Additionally, Astellas is working to reduce absolute Scope 3 GHG emissions by 37.5% by fiscal year 2030, also against a fiscal year 2015 baseline, with the goal aligned with a 1.5°C pathway. These targets are validated by the Science Based Targets initiative (SBTi).